Bharat Bio launches recombinant streptokinase
Bharat Biotech International Ltd (BBIL), the city-based bio pharmaceutical company, has announced the launch of recombinant streptokinase, the first line therapy for myocardial infarction (heart
Bharat Biotech International Ltd (BBIL), the city-based bio pharmaceutical company, has announced the launch of recombinant streptokinase, the first line therapy for myocardial infarction (heart